A year to remember: Celebrating Bowel Cancer UK's successful partnership with the BIA

Kelsey Lawrence .png

In this blog, Kelsey Lawrence, the Senior Corporate Partnerships Officer for Bowel Cancer UK, reflects on the highlights of the charity partnership with BIA during 2023. She concludes by extending gratitude to members and all who made the partnership impactful. 


On behalf of the Bowel Cancer UK team, thank you to everyone in the BIA community for embracing us so warmly and making this partnership such a success. As the Senior Corporate Partnerships Officer for Bowel Cancer UK, I’ve had the great privilege to get to work alongside your brilliant organisation. I’m so proud of what we’ve achieved together and wanted to take a moment to look back on our amazing year.

At the heart of our partnership was a touching tribute to the late Aisling Burnand CBE, someone who was deeply connected to Bowel Cancer UK and the BIA. Aisling's legacy became a driving force behind our work together and inspired our shared commitment to transforming the treatment and care for bowel cancer patients. As well as being a previous CEO of the BIA she was also a valued trustee of our charity who is greatly missed. We know that she’d be proud to see everything we’ve achieved together.

The year started in style with the annual BIA Gala Dinner. The flagship event saw 650 of you from across the BIA membership come together in London, for networking and captivating speeches, including from Dr Anisha Patel. Anisha shared her unique and moving perspective as both a bowel cancer patient and GP, honestly recounting the turbulent reality of living with and beyond the disease. Thanks to the incredible generosity of attendees, we raised over £30,000 on the night.   

Another highlight was the brand new '5 Biotech Wonders of the World' challenge. Teams leapt at the chance to cover long virtual distances from the BIA office in London to five Biotech hubs around the world. Excitingly after many days of fierce competition to cover the furthest distance, and raise the most money, team MaxCyte Sparks ultimately triumphed with Team Astex Athletes in second place and Gallagher Life Sciences Practice coming in third. Your collective efforts of walking, running, swimming, and cycling not only reached impressive distances but also symbolized the journey we’re making to a world where no one dies from bowel cancer.

Thanks to your determined support, an amazing sum of over £70,000 was raised for Bowel Cancer UK's crucial work making this one of the biggest charity partnerships we have had to date. This incredible sum of money will have a big impact and is enough to fund three pilot grants to test innovations that help patients get earlier diagnoses and improve their chances of survival.

Your support means we can help more people like Clare access new and innovative treatments that are right for them: “I think the statistics for people like me diagnosed with stage 4 bowel cancer are appalling. I want to help make sure others don't get the news I have, and research is the only way to improve treatments and find ways to prevent it too."

We’ve thoroughly enjoyed being part of the membership this year and have had the pleasure of meeting so many of you, hearing about your work and exploring ways we can work together. If you’d like to explore ways we can partner in the future, I’d be delighted to hear from you via [email protected] to continue to deepen the legacy of our partnership.

Thank you.

 

More news and updates

A critical time for AI, dementia and better brain health

Ahead of BioBeat24, Iraida Soria-Espinosa, Senior Innovation & Business Manager at UK DRI, and Miranda Weston-Smith, Founder of BioBeat, caught up with keynote speaker Zoe Kourtzi, Professor of Computational Cognitive Neuroscience at the University of Cambridge.

CEO Update - 7 May 2024

It’s SynBioBeta week and the UK engineering biology community is out in force in San Jose, California. The BIA is leading a coalition of UK stakeholders to showcase the dynamism and innovation of the UK's companies. Read on for updates on local election results, Innovation Map and Deaf Awareness Week...

Paul Freemont's speech on engineering biology at 10 Downing Street reception

Professor Paul Freemont, Faculty of Medicine, Department of Infectious Disease at Imperial College shares insights from his speech at the 10 Downing Street reception. Discover the dynamic landscape of UK engineering biology, where innovation meets sustainability, and explore the vibrant ecosystem of pioneering companies poised to revolutionize industries worldwide.

Deep Biotech companies using engineering biology for good: Evonetix case study

Evonetix is developing a new tool that lets researchers build the building blocks of life – genes – faster and easier than ever before. This could lead to breakthroughs in medicine and agriculture. Read more in BIA's Deep Biotech report on disruptive innovation for global sustainability.

CEO Update - 29 April 2024

Much of the UK will go to the polls this Thursday in the biggest test of public opinion ahead of the UK general election. Ten key metro mayoral contests take place including in Tees Valley, Manchester, the West and East Midlands and London. The results will be announced over the weekend and give a new mandate to key figures in regions of the UK whilst also helping define if we will have a summer or autumn general election.

Harnessing the power of innovation: How the Innovation Map can help your life science company thrive

In this blog, Sam Cruickshank, Programme Manager at BIA, discusses the pivotal role of the recently updated 2024 BIA Innovation Map in empowering life science entrepreneurs to navigate the complexities of the start-up landscape and unlock their ventures' full potential.

RNID shine a spotlight on the hearing therapeutics landscape

In this blog, Melissa Hayman, Hearing Therapeutics Manager at RNID, BIA’s charity partner of the year introduces a blog series to be published over the coming months which will examine the hearing therapeutics landscape.

Continuity and change: Labour’s life science strategy

​​​​Herbie Lambden, Senior Policy and Public Affairs Executive at the BIA, provides a rundown of the BIA Committee Summit, which took place in Westminster on 21 February.

CEO Update - 22 April 2024

The UK's engineering biology scene was out in force at a Number 10 Downing Street reception last week. It was great to celebrate the developments in our community network together with ministers and investors.

Step up and create more inclusive workplaces within the biotech sector

In last year’s Diversity and Inclusion in UK Biotech survey conducted by the BIA, hearing loss emerged as one of the most prevalent disabilities. With Deaf Awareness Week 2024 (6-12 May) fast approaching, the BIA has teamed up with its charity partner, RNID, to offer valuable resources and initiatives for creating more inclusive workplaces across the biotech sector.

 

More within